Robert Jenkins, M.D., Ph.D., Discusses Glioma Research

By Kelley Luedke • September 14, 2015

Share this:

Bill Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology in Rochester, Minn., sat down with Robert Jenkins, M.D., Ph.D., Consultant in the Division of Laboratory Genetics, to chat with him about his glioma research and the recent study published in the New England Journal of Medicine on which Dr. Jenkins is the principal author.

Dr. Jenkins explained that his research looks at the genetics of gliomas. About 20 years ago, his laboratory found an alteration in glioma DNA. Then, about five years ago, two other laboratories discovered two more alterations. Dr. Jenkins’ team tested those three alterations and found that they could put the gliomas into DNA categories completely independent of the pathology.

Watch the video below for the full interview:

Kelley Luedke

Kelley Luedke is a Marketing Channel Manager at Mayo Clinic Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her kitty, and exploring new foods.